FORA Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-1,986
| Closed | -$242K | – | 920 |
|
2021
Q1 | $242K | Sell |
1,986
-13,560
| -87% | -$1.65M | 0.08% | 259 |
|
2020
Q4 | $2.38M | Buy |
15,546
+15,029
| +2,907% | +$2.3M | 0.36% | 56 |
|
2020
Q3 | $43K | Sell |
517
-10,198
| -95% | -$848K | 0.03% | 460 |
|
2020
Q2 | $787K | Buy |
+10,715
| New | +$787K | 0.27% | 92 |
|
2020
Q1 | – | Sell |
-2,598
| Closed | -$158K | – | 1080 |
|
2019
Q4 | $158K | Buy |
+2,598
| New | +$158K | 0.02% | 669 |
|